Magdalena W.
- Country
- Poland
- Department
- Oddział Hematologii i Transplantologii Szpiku
Research Overview
- A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
- Phase III Randomized Study of Lurbinectedin Alone or with Irinotecan Versus Topotecan or Irinotecan in Relapsed Small Cell Lung Cancer Patients
Data & Insights
Has run more than one trial at 38 of 256 partner sites.
Specializations
Lung Cancer Research
This investigator specializes in the treatment of small cell lung cancer (SCLC), with particular focus on therapeutic approaches for patients who have experienced disease progression after initial treatment.
- Advanced SCLC Management
- Second-line Treatment Strategies
- Platinum-resistant Disease
The investigator explores innovative therapeutic interventions for patients with relapsed SCLC, evaluating novel treatment combinations to enhance survival outcomes.
Novel Therapeutics
The investigator focuses on evaluating emerging anticancer agents and their potential in treating resistant forms of lung cancer. Their work includes assessment of lurbinectedin as both monotherapy and combination treatment.
- Single-Agent Therapies
- Combination Treatment Approaches
- Drug Resistance Mechanisms
Their research encompasses comparative analyses of different therapeutic regimens to identify optimal treatment strategies for relapsed disease.
Treatment Optimization
The investigator studies survival outcomes in advanced lung cancer, focusing on comparing established treatments with newer therapeutic options. Their work involves evaluation of chemotherapy alternatives for resistant disease.
- Treatment Selection Criteria
- Sequential Therapy Approaches
- Patient Response Assessment
Their research aims to establish evidence-based treatment selection criteria for patients with progressive disease after initial therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.